BAKER JULIAN
- SEC CIK
- 0001087939
Latest role at each company
- ONC BeOne Medicines Ltd.Directoras of Sep 16, 2026
- REPL Replimune Group, Inc.Director, 10% Owneras of Aug 11, 2026
- CELC Celcuity Inc.Other: Former 10% owneras of Jul 16, 2026
- KOD Kodiak Sciences Inc.Director, 10% Owneras of Jul 2, 2026
- INCY INCYTE CORPDirector, 10% Owneras of Jul 2, 2026
Show 19 more companies
- VTVT vTv Therapeutics Inc.Directoras of Jun 29, 2026
- KYMR Kymera Therapeutics, Inc.Director, 10% Owneras of Jun 25, 2026
- MDGL MADRIGAL PHARMACEUTICALS, INC.Directoras of Jun 18, 2026
- PRLD Prelude Therapeutics IncDirector, 10% Owneras of Jun 10, 2026
- DNLI Denali Therapeutics Inc.Directoras of Jun 5, 2026
- ACAD ACADIA PHARMACEUTICALS INCDirector, 10% Owneras of Jun 2, 2026
- KNSA Kiniksa Pharmaceuticals International, plcDirectoras of Jun 2, 2026
- TCRX TScan Therapeutics, Inc.Directoras of May 22, 2026
- DBVT DBV Technologies S.A.Directoras of Jan 14, 2026
- BCYC BICYCLE THERAPEUTICS PLCDirector, 10% Owneras of Jan 6, 2026
- TRDA Entrada Therapeutics, Inc.10% Owneras of Nov 24, 2025
- KALA KALA BIO, Inc.Other: Former 10% owneras of Oct 2, 2025
- CIK 0001496323Other: Former 10% owner and directoras of Aug 18, 2025
- IMCR Immunocore Holdings plcDirectoras of May 19, 2025
- NGNE Neurogene Inc.Director, Other: Former 10% Owneras of Dec 20, 2023
- CIK 0001060736Director, Other: Former 10% Owneras of Dec 18, 2023
- CIK 000135840310% Owneras of Nov 24, 2023
- CIK 0001532346Other: Former 10% Owneras of Oct 23, 2023
- CIK 0001584751Director, 10% Owneras of Jun 13, 2023
Trades
Every Form 4 that lists BAKER JULIAN as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| REPLReplimune Group, Inc. | Aug 11, 20265:46 PM ET | Aug 11, 2026 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock · Derivative | +2.74M | $12.0599 | +$33M | 2.61M | – | SEC |
| CELCCelcuity Inc. | Jul 16, 20265:42 PM ET | Jul 14, 2026 | BAKER JULIAN and 3 othersOther: Former 10% owner | SSaleCommon Stock | −3.1M | $102.50 | −$317.75M | 4.37M | −41.5% | SEC |
| ONCBeOne Medicines Ltd. | May 27, 20264:54 PM ET | May 22, 2026 | BAKER JULIAN and 5 othersDirector | SSaleOrdinary Shares | −11K | $23.8208 | −$261.98K | 142.57K | −7.2% | SEC |
| PRLDPrelude Therapeutics Inc | Apr 22, 20264:15 PM ET | Apr 21, 2026 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock · Derivative | +2.25M | $4.4399 | +$10M | 20.11M | – | SEC |
| KODKodiak Sciences Inc. | Dec 19, 20254:06 PM ET | Dec 18, 2025 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +2.61M | $23.00 | +$60M | 18.36M | +16.6% | SEC |
| DNLIDenali Therapeutics Inc. | Dec 15, 20254:33 PM ET | Dec 11, 2025 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock · Derivative | +2.29M | $17.49 | +$39.98M | 26M | – | SEC |
| KYMRKymera Therapeutics, Inc. | Dec 11, 20254:19 PM ET | Dec 11, 2025 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +2.01M | $86.00 | +$172.5M | 7.96M | +33.7% | SEC |
| TRDAEntrada Therapeutics, Inc. | Nov 24, 20254:09 PM ET | Nov 20, 2025 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock | +28.87K | $9.0708 | +$261.85K | 4.69M | +0.6% | SEC |
| TRDAEntrada Therapeutics, Inc. | Nov 12, 20255:34 PM ET | Nov 10 – Nov 12, 2025 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock | +178.04K | $7.5969 | +$1.35M | 4.66M | +4.0% | SEC |
| KALAKALA BIO, Inc. | Oct 2, 20254:47 PM ET | Sep 30 – Oct 1, 2025 | BAKER JULIAN and 3 othersOther: Former 10% owner | SSaleCommon Stock | −730.41K | $1.4468 | −$1.06M | 425.01K | −63.2% | SEC |
| CELCCelcuity Inc. | Sep 10, 20254:06 PM ET | Sep 8, 2025 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock | +170.1K | $56.2688 | +$9.57M | 7.21M | +2.4% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Aug 20, 20256:12 PM ET | Aug 18 – Aug 20, 2025 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +97.07K | $380.5821 | +$36.94M | 1.95M | +5.2% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Aug 20, 20256:09 PM ET | Aug 18, 2025 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +68.62K | $364.0419 | +$24.98M | 1.86M | +3.8% | SEC |
| KYMRKymera Therapeutics, Inc. | Jun 30, 20258:15 PM ET | Jun 30, 2025 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +655.5K | $44.00 | +$28.84M | 6.12M | +12.0% | SEC |
| KYMRKymera Therapeutics, Inc. | Jun 30, 20258:15 PM ET | Jun 30, 2025 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock · Derivative | +655.5K | $43.9999 | +$28.84M | 10.23M | – | SEC |
| IMCRImmunocore Holdings plc | Mar 19, 20256:40 PM ET | Mar 17, 2025 | BAKER JULIAN and 5 othersDirector | PPurchaseAmerican Depositary Shares | +807.34K | $29.7189 | +$23.99M | 2.14M | +60.4% | SEC |
| IMCRImmunocore Holdings plc | Mar 19, 20256:40 PM ET | Mar 17, 2025 | BAKER JULIAN and 5 othersDirector | SSaleAmerican Depositary Shares · Derivative | −1.58M | – | – | 0 | – | SEC |
| ONCBeOne Medicines Ltd. | Feb 28, 20259:28 PM ET | Feb 28, 2025 | BAKER JULIAN and 5 othersDirector | SSaleAmerican Depositary Shares | −732.83K | $260.00 | −$190.54M | 8.07M | −8.3% | SEC |
| KALAKALA BIO, Inc. | Dec 31, 20244:00 PM ET | Dec 30, 2024 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock | +310.56K | $6.44 | +$2M | 1.08M | +40.2% | SEC |
| BCYCBICYCLE THERAPEUTICS PLC | Dec 17, 20246:03 PM ET | Dec 13 – Dec 16, 2024 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +1.49M | $14.2927 | +$21.23M | 10M | +17.5% | SEC |
| ONCBeOne Medicines Ltd. | Dec 10, 20249:25 PM ET | Dec 9, 2024 | BAKER JULIAN and 5 othersDirector | SSaleAmerican Depositary Shares | −1.04M | $187.2679 | −$194.2M | 8.74M | −10.6% | SEC |
| KYMRKymera Therapeutics, Inc. | Aug 22, 20244:03 PM ET | Aug 20, 2024 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +1 | $46.41 | +$46.41 | 5.52M | 0.0% | SEC |
| KYMRKymera Therapeutics, Inc. | Aug 22, 20244:03 PM ET | Aug 21, 2024 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock · Derivative | +2.59M | $40.7499 | +$105.71M | 9.63M | – | SEC |
| TRDAEntrada Therapeutics, Inc. | Jun 26, 20244:53 PM ET | Jun 25, 2024 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock · Derivative | +3.37M | $14.8499 | +$50M | 3.08M | – | SEC |
| TCRXTScan Therapeutics, Inc. | Apr 23, 20244:17 PM ET | Apr 19, 2024 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock · Derivative | +9.68M | $7.1299 | +$69M | 43.16M | – | SEC |
| – | Mar 28, 20247:04 PM ET | Mar 26 – Mar 28, 2024 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +395.32K | $8.6654 | +$3.43M | 3.75M | +11.8% | SEC |
| – | Dec 15, 20235:32 PM ET | Dec 13 – Dec 15, 2023 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +532.69K | $6.4417 | +$3.43M | 3.39M | +18.6% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Dec 14, 20236:10 PM ET | Dec 13 – Dec 14, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +101.79K | $221.2018 | +$22.52M | 1.79M | +6.0% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Dec 14, 20236:09 PM ET | Dec 12, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +34.58K | $218.3069 | +$7.55M | 1.7M | +2.1% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Nov 21, 20236:15 PM ET | Nov 21, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +64.35K | $188.4746 | +$12.13M | 1.67M | +4.0% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Nov 21, 20236:14 PM ET | Nov 17 – Nov 20, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +67.08K | $178.1076 | +$11.95M | 1.61M | +4.4% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Nov 15, 20235:13 PM ET | Nov 14 – Nov 15, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +49.39K | $158.1298 | +$7.81M | 1.55M | +3.3% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Nov 15, 20235:12 PM ET | Nov 13 – Nov 14, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock | +107.5K | $146.9876 | +$15.8M | 1.5M | +7.7% | SEC |
| ONCBeOne Medicines Ltd. | Nov 14, 20235:54 PM ET | Nov 14, 2023 | BAKER JULIAN and 5 othersDirector, 10% Owner | SSaleAmerican Depositary Shares | −1.1M | $180.50 | −$198.55M | 9.69M | −10.2% | SEC |
| – | Oct 23, 20234:49 PM ET | Oct 19, 2023 | BAKER JULIAN and 3 othersOther: Former 10% Owner | SSaleClass A common stock | −274.74K | $0.4025 | −$110.58K | 2.97M | −8.5% | SEC |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | Oct 5, 20234:27 PM ET | Oct 3, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock · Derivative | +1.65M | $151.6899 | +$250M | 1.52M | – | SEC |
| NGNENeurogene Inc. | Aug 17, 20235:08 PM ET | Aug 15 – Aug 17, 2023 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +2.29M | $0.6404 | +$1.46M | 5.61M | +68.7% | SEC |
| – | Jun 28, 20235:00 PM ET | Jun 26, 2023 | BAKER JULIAN and 5 othersDirector | PPurchaseCommon Stock · Derivative | +5.63M | $8.00 | +$45M | 9.89M | – | SEC |
| ACADACADIA PHARMACEUTICALS INC | May 24, 20235:09 PM ET | May 22 – May 24, 2023 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +896.52K | $25.328 | +$22.71M | 39.32M | +2.3% | SEC |
| KODKodiak Sciences Inc. | Jun 6, 20225:08 PM ET | Jun 2 – Jun 6, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +572.35K | $7.7718 | +$4.45M | 15.97M | +3.7% | SEC |
| TRDAEntrada Therapeutics, Inc. | Jun 6, 20225:07 PM ET | Jun 2 – Jun 6, 2022 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock | +40.95K | $6.3682 | +$260.76K | 4.5M | +0.9% | SEC |
| KODKodiak Sciences Inc. | May 27, 20224:44 PM ET | May 25 – May 27, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +350.41K | $6.7457 | +$2.36M | 15.46M | +2.3% | SEC |
| TRDAEntrada Therapeutics, Inc. | May 24, 20226:39 PM ET | May 20 – May 24, 2022 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock | +48.51K | $5.8226 | +$282.45K | 4.47M | +1.1% | SEC |
| TRDAEntrada Therapeutics, Inc. | May 18, 20225:38 PM ET | May 16 – May 18, 2022 | BAKER JULIAN and 3 others10% Owner | PPurchaseCommon Stock | +71.94K | $5.9866 | +$430.7K | 4.42M | +1.7% | SEC |
| KODKodiak Sciences Inc. | May 18, 20225:30 PM ET | May 16 – May 18, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +456.69K | $5.9052 | +$2.7M | 15.14M | +3.1% | SEC |
| TCRXTScan Therapeutics, Inc. | May 12, 20224:41 PM ET | May 10 – May 11, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +1.36M | $1.882 | +$2.56M | 2.53M | +116.3% | SEC |
| – | Apr 5, 20224:32 PM ET | Apr 1, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock · Derivative | +2.83M | $23.00 | +$65M | 4.67M | – | SEC |
| INCYINCYTE CORP | Mar 10, 20226:02 PM ET | Mar 8 – Mar 10, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +389.08K | $72.2416 | +$28.11M | 33.42M | +1.2% | SEC |
| INCYINCYTE CORP | Feb 22, 20225:45 PM ET | Feb 17 – Feb 22, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +525.8K | $67.9624 | +$35.73M | 33.04M | +1.6% | SEC |
| KODKodiak Sciences Inc. | Feb 17, 20225:33 PM ET | Feb 15 – Feb 17, 2022 | BAKER JULIAN and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +400.97K | $54.449 | +$21.83M | 14.73M | +2.8% | SEC |